Evidence map›Paper›PMID 19897716›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Reovirus nonstructural protein sigma1s is required for establishment of viremia and systemic dissemination.

Karl W Boehme, Kristen M Guglielmi, Terence S Dermody

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Journal of virology · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The Orchestra of Reovirus Cell Entry.Current clinical microbiology reports · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Karl W BoehmeDepartment of Pediatrics, and the Elizabeth B. Lamb Center for Pediatric Research, D7235 Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Kristen M Guglielmi
Terence S Dermody
Vanderbilt University Medical Center · USBipar · FR

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
TRAINING PROGRAM IN CELLULAR, BIOCHEMICAL, &MOLECULAR ST32GM008554 · NIGMS · VANDERBILT UNIVERSITY · PI PATTON, JAMES G. · 1995 to 2020
$7.4M
VIRUSES, NUCLEIC ACIDS, GROWTH, AND CANCERT32CA009385 · NCI · VANDERBILT UNIVERSITY · PI RULEY, HENRY EARL · 1985 to 2007
$4.1M
Molecular Basis of Reovirus PathogenesisR37AI038296 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DERMODY, TERENCE S. · 2006 to 2015
$3.7M
Characterization of the reovirus simga 1s protien.F32AI075776 · NIAID · VANDERBILT UNIVERSITY · PI BOEHME, KARL W · 2008 to 2008
$50k
NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NCI NIH HHS T32 CA009385NCI NIH HHS T32 CA09385NIAID NIH HHS F32 AI075776NIAID NIH HHS F32AI075776NIAID NIH HHS R37 AI038296NIAID NIH HHS R37 AI38296NIDDK NIH HHS DK20593NIDDK NIH HHS P30 DK020593NIGMS NIH HHS T32 GM008554NIGMS NIH HHS T32 GM08554
6 · The paper itself

Abstract

Serotype-specific patterns of reovirus disease in the CNS of newborn mice segregate with the viral S1 gene segment, which encodes attachment protein sigma1 and nonstructural protein sigma1s. The importance of receptor recognition in target cell selection by reovirus implicates the sigma1 protein as the primary effector of disease outcome. However, the contribution of sigma1s to reovirus disease is unknown. To define the function of sigma1s in reovirus pathogenesis, we generated a sigma1s-deficient virus by altering a single nucleotide to disrupt the sigma1s translational start site. Viruses were recovered that contain nine gene segments from strain type 3 Dearing and either the wild-type or sigma1s-null S1 gene segment from strain type 1 Lang. Following peroral inoculation of newborn mice, both viruses replicated in the intestine, although the wild-type virus achieved higher yields than the sigma1s-null virus. However, unlike the wild-type virus, the sigma1s-deficient virus failed to disseminate to sites of secondary viral replication, including the brain, heart, and liver. Within the small intestine, both viruses were detected in Peyer's patches, but only the wild-type virus reached the mesenteric lymph node. Concordantly, wild-type virus, but not sigma1s-deficient virus, was detected in the blood of infected animals. Wild-type and sigma1s-null viruses produced equivalent titers following intracranial inoculation, indicating that sigma1s is dispensable for viral growth in the murine CNS. These results suggest a key role for sigma1s in virus spread from intestinal lymphatics to the bloodstream, thereby allowing the establishment of viremia and dissemination to sites of secondary replication within the infected host.

Indexed as

ViremiaVirus ReplicationAnimalsAnimals, NewbornBrainCells, CulturedMammalian orthoreovirus 3MiceMice, Inbred C57BLOrthoreovirus, MammalianReoviridae InfectionsViral Nonstructural Proteinssigma 1NS protein, ReovirusViral Nonstructural Proteins

Identifiers

PMID19897716
PMCPMC2774258
OpenAlexW1999853046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.